|
1.
|
|
19 p, 1.5 MB |
Neurofilaments contribution in clinic : state of the art
/
Delaby, Constance (Institut d'Investigació Biomèdica Sant Pau) ;
Bousiges, Olivier (Laboratoire de biochimie et biologie moléculaire (LBBM)-Pôle de biologie Hôpital de Hautepierre-CHU de Strasbourg. CNRS. laboratoire ICube UMR 7357 et FMTS (Fédération de Médecine Translationnelle de Strasbourg). équipe IMIS) ;
Bouvier, Damien (Service de Biochimie et Génétique Moléculaire. CHU de Clermont-Ferrand) ;
Fillée, Catherine (Cliniques universitaires Saint-Luc UCLouvain. Service de Biochimie Médicale) ;
Fourier, Anthony (Biochimie et Biologie Moléculaire-LBMMS. Unité de diagnostic des pathologies dégénératives. Centre de Biologie et Pathologie Est. Groupement Hospitalier Est) ;
Mondésert, Etienne (Université de Montpellier. IRMB. INM. INSERM. CHU de Montpellier. Laboratoire Biochimie-Protéomique clinique) ;
Nezry, Nicolas (Univ. Lille. Inserm. CHU Lille. UMR-S-U1172. LiCEND. Lille Neuroscience Cognition. LabEx DISTALZ) ;
Omar, Souheil (Laboratoire de biologie médicale de l'Institut de Neurologie de Tunis) ;
Quadrio, Isabelle (Biochimie et Biologie Moléculaire-LBMMS. Unité de diagnostic des pathologies dégénératives. Centre de Biologie et Pathologie Est. Groupement Hospitalier Est) ;
Rucheton, Benoit (Laboratoire de Biologie. Institut Bergonié) ;
Schraen-Maschke, Susanna (Univ. Lille. Inserm. CHU Lille. UMR-S-U1172. LiCEND. Lille Neuroscience Cognition. LabEx DISTALZ) ;
van Pesch, Vincent (Cliniques universitaires Saint-Luc UCLouvain. Service de Neurologie) ;
Vicca, Stéphanie (Hôpital Necker-Enfants malades. Paris. Laboratoire de Biochimie générale. DMU BioPhyGen. AP-HP.Centre-Université de Paris) ;
Lehmann, Sylvain (Université de Montpellier. IRMB. INM. INSERM. CHU de Montpellier. Laboratoire Biochimie-Protéomique clinique) ;
Bedel, Aurelie (Service de Biochimie. CHU Pellegrin) ;
Universitat Autònoma de Barcelona
Neurological biomarkers are particularly valuable to clinicians as they can be used for diagnosis, prognosis, or response to treatment. This field of neurology has evolved considerably in recent years with the improvement of analytical methods, allowing the detection of biomarkers not only in cerebrospinal fluid (CSF) but also in less invasive fluids like blood. [...]
2022 -  10.3389/fnagi.2022.1034684
Frontiers in aging neuroscience, Vol. 14 (january 2022) , p. 1034684
|
|
|
2.
|
|
12 p, 774.2 KB |
Kappa free light chains is a valid tool in the diagnostics of MS : A large multicenter study
/
Leurs, C. E. (VU University Medical Center. Department of Neurology) ;
Twaalfhoven, Ham (Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry) ;
Lissenberg-Witte, B. I. (Department of Epidemiology and Biostatistics, Amsterdam UMC) ;
van Pesch, V (Department of Neurology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain) ;
Dujmovic, Irena (Clinic of Neurology, Clinical Centre of Serbia, School of Medicine, University of Belgrade) ;
Drulovic, Jelena (Clinic of Neurology, Clinical Centre of Serbia, School of Medicine, University of Belgrade) ;
Castellazzi, M. (Department of Biomedical and Specialty Surgical Sciences, University of Ferrara) ;
Bellini, T. (Department of Biomedical and Specialty Surgical Sciences, University of Ferrara) ;
Pugliatti, M. (Department of Biomedical and Specialty Surgical Sciences, University of Ferrara) ;
Kuhle, Jens (Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedicine, University Hospital Basel) ;
Villar, L. M. (Hospital Ramón y Cajal. Departamento de Inmunologia) ;
Alvarez-Cermeño, José C (Hospital Ramón y Cajal. Departamento de Neurologia) ;
Alvarez-Lafuente, Roberto (Instituto de Investigación Sanitaria San Carlos) ;
Hegen, Harald (Department of Neurology, Medical University of Innsbruck) ;
Deisenhammer, Florian (Department of Neurology, Medical University of Innsbruck) ;
Walchhofer, L. M. (Department of Neurology, Medical University of Innsbruck) ;
Thouvenot, Eric (Hôpital Caremeau, Nîmes. Departement of Neurology) ;
Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vécsei, L. (Department of Neurology, University of Szeged) ;
Rajda, C. (Department of Neurology, University of Szeged) ;
Galimberti, Daniela (Multiple Sclerosis Centre, University of Milan) ;
Scarpini, E. (Multiple Sclerosis Centre, University of Milan) ;
Altintas, Ayse (Koc University, School of Medicine, Neurology Department) ;
Rejdak, K. (Department of Neurology, Medical University of Lublin) ;
Frederiksen, J. L. (Department of Neurology, Rigshospitalet Glostrup and University of Copenhagen) ;
Pihl-Jensen, G. (Department of Neurology, Rigshospitalet Glostrup and University of Copenhagen) ;
Jensen, Peh (Danish Multiple Sclerosis Centre, Department of Neurology, Rigshospitalet, University of Copenhagen) ;
Khalil, Michael (Department of Neurology, Medical University of Graz) ;
Voortman, Margarete (Department of Neurology, Medical University of Graz) ;
Fazekas, F. (Department of Neurology, Medical University of Graz) ;
Saiz, Albert (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
La Puma, D. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Vercammen, M. (Department of Laboratory Medicine, AZ Sint-Jan Brugge-Oostende) ;
Vanopdenbosch, L. (Department of Neurology, AZ Sint-Jan Brugge-Oostende) ;
Uitdehaag, BMJ (Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC) ;
Killestein, Joep (Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC) ;
Bridel, C. (Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry) ;
Teunissen, Charlotte E. (Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
To validate kappa free light chain (KFLC) and lambda free light chain (LFLC) indices as a diagnostic biomarker in multiple sclerosis (MS). We performed a multicenter study including 745 patients from 18 centers (219 controls and 526 clinically isolated syndrome (CIS)/MS patients) with a known oligoclonal IgG band (OCB) status. [...]
2019 - 10.1177/1352458519845844
Multiple sclerosis, Vol. 26 (may 2019) , p. 912-923
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
